Week of June 28th 2021 | Vol. 10, Issue 26 |
|
In This Issue
Featured Headlines
Recent Industry Transactions
Industry Trading Comps
Recent Industry Headlines
Market Reports
Upcoming Events
Quick Links
Contact Information
Managing Director
Business Development
Managing Director
Head of M&A and Capital Advisory
|
|
Above is an overview of recent industry M&A activity. For additional information, see the charts below or click on the chart above to download complete transaction tables broken out by industry sub sectors.
|
|
For more information about our consumer healthcare JV with The Emerson Group, Daybreak Consumer Care, click here.
|
|
MARKET REPORTS
Recent Materials Providing Insight Into Healthcare Related Industries
|
|
Current M&A Pipeline
Representative Current Retained Sell-Side And Partnering Opportunities
|
|
Project Focus
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in North America
Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
Project Aspen
Sell-side | CDMO | Multinational CDMO headquartered in US
Project Athena
Sell-side / Licensing | Medical Device | Novel device for pelvic organ prolapse
|
|
Outpatient imaging center operator Akumin is acquiring Alliance HealthCare Services to get a bigger slice of the radiology and oncology services market.
Irvine, California-based Alliance HealthCare Services provides services in oncology and radiology to more than 1,000 hospitals, health systems and physicians' practices in 45 states.
The deal is valued at $820 million and is expected to close in the third quarter, subject to antitrust approval from U.S. regulators.
If the deal is approved, the combined company will generate annual revenue of more than $730 million with adjusted earnings before interest, taxes, depreciation and amortization of $210 million, according to an investor presentation.
Alliance is owned by Tahoe Investment Group, a Chinese financial firm, which acquired the healthcare company for $178 million through two separate transactions in 2016 and 2017 and then took it private, according to Bloomberg. The publication reported back in August that Tahoe was potentially seeking a sale and could fetch upward of $400 million.
|
|
RECENT INDUSTRY TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
|
|
Pharma & Biotech
7 transactions totaling $402 million
Supplies, Equipment & Services
21 transactions totaling $3,123 million
Healthcare IT & Managed Care
10 transactions totaling $170 million
Healthcare Facilities & Distributors
14 transactions totaling $939 million
|
|
Pharma & Biotech
31 transactions totaling $648 million
Supplies, Equipment & Services
25 transactions totaling $798 million
Healthcare IT & Managed Care
15 transactions totaling $595 million
Healthcare Facilities & Distributors
0 transactions
|
|
Pharma & Biotech
17 transactions totaling $1,348 million
Supplies, Equipment & Services
5 transactions totaling $528 million
Healthcare IT & Managed Care
1 transaction totaling $1,800 million
Healthcare Facilities & Distributors
3 transactions totaling $2,571 million
|
|
INDUSTRY TRADING COMPS
A Breakdown of Relevant Trading Multiples
Each week, we provide updated trading comps for leading companies from numerous healthcare sub-sectors.
|
|
To the right you will see a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.
For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table.
Note: data reflects prior week close.
|
|
|
RECENT INDUSTRY TRANSACTIONS
A Sampling of Relevant Industry Headlines from Last Week
Below are snippets from relevant industry news articles from the past week. For additional information or the article's complete text, click the headline link to view the original publication.
|
|
June 25, 2021 - Pharmaceutical Business Review
AbbVie is set to acquire Teneobio affiliate TeneoOne and its lead drug candidate TNB-383B, which is being developed to treat relapsed or refractory multiple myeloma (R/R MM). The deal is made possible via AbbVie’s exercise of its exclusive right to purchase TeneoOne and TNB-383B.
June 25, 2021 - Contract Pharma
Catalent, a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, has reached an agreement to acquire RheinCell Therapeutics GmbH, a developer and manufacturer of GMP-grade human induced pluripotent stem cells (iPSCs).
June 24, 2021 - Pharmaceutical Business Review
GlaxoSmithKline (GSK) has plans to spin off its Consumer Healthcare unit by demerging a minimum of 80% of the company’s 68% stake to its shareholders.
June 24, 2021 - Fierce Pharma
The head of the World Health Organization pleaded with richer nations to supply poor countries with more vaccines. The U.S. will stop distributing doses of Eli Lilly's antibody combo treatment because of circulating variants. The worldwide case count stood at more than 180.1 million on Friday afternoon, with more than 3.9 million reported deaths, according to Johns Hopkins University's COVID-19 dashboard.
|
|
Welcome to Bourne, let's talk.
Since our founding in 2001, Bourne Partners has remained focused on fulfilling the unique needs of established, middle-market healthcare and pharmaceutical companies across the globe. Our track record includes advising middle market companies in healthcare M&A assignments totaling more than $7 billion, and growing companies into successful and well-positioned pharmaceutical enterprises.
|
|
|
|
|
|
|
